77 results
Page 2 of 4
8-K
EX-1.1
7ce1re
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
r24s4ponipr
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
ie7dn2pn5t
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
7d11pui s0z1xko
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
CORRESP
xuwme
5 Feb 21
Correspondence with SEC
12:00am
8-K
4vewq 83yt906a1e
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
hisn0v8nhzdm
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
9nhzy r5go2kw1oh3
26 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-1.1
zbax5045hcsb2dekn
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
vom l4kvprne4
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
h6jc7on6ib fktd6
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
iaj2 m754ge
25 Oct 19
Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock
4:03pm
CORRESP
rcqf57m
22 Jul 19
Correspondence with SEC
12:00am